Moberg Pharma AB (publ) (STO:MOB)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.33
-0.04 (-0.43%)
Jul 24, 2026, 5:19 PM CET

Moberg Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
230.95293.2960.56125.55102.66
Cash & Short-Term Investments
230.95293.2960.56125.55102.66
Cash Growth
-21.25%384.33%-51.77%22.30%-21.65%
Accounts Receivable
2.330.17-0.380.47
Other Receivables
0.370.640.791.060.66
Total Trade Receivables
2.70.80.791.441.14
Inventory
3.584.37.12--
Other Current Assets
0.691.731.040.770.86
Total Current Assets
237.91300.1169.49127.76104.66
Net Property, Plant & Equipment
2.814.424.945.984.52
Other Intangible Assets
--532.22408.1327.04
Other Long-Term Assets
92.5895.7828.0822.5814.67
Total Assets
682.26706.09634.73564.42450.89
Accounts Payable
2.934.166.7717.115.31
Accrued Expenses
9.428.989.236.546.57
Current Portion of Leases
1.681.61.272.122.7
Other Current Liabilities
2.151.983.271.020.97
Total Current Liabilities
16.1716.7220.5426.7915.54
Long-Term Leases
0.872.553.473.991.24
Other Long-Term Liabilities
---0.070.07
Total Long-Term Liabilities
0.872.553.474.051.3
Total Liabilities
17.0419.2724.0130.8416.84
Common Stock
4746.6927.969.834.41
Additional Paid-in Capital
1,2391,234921.3841.2731.38
Retained Earnings
-620.88-593.64-338.53-317.44-301.73
Total Common Shareholders' Equity
665.22686.82610.73533.58434.05
Shareholders' Equity
665.22686.82610.73533.58434.05
Total Liabilities & Equity
682.26706.09634.73564.42450.89
Total Debt
2.554.144.746.113.93
Net Cash (Debt)
228.4289.1555.82119.4598.72
Net Cash Growth
-21.01%418.02%-53.27%20.99%-20.14%
Net Cash Per Share
4.747.431.5715.4122.37
Book Value
665.22686.82610.73533.58434.05
Book Value Per Share
13.8017.6517.1968.8398.35
Tangible Book Value
665.22686.8278.51125.48107.01
Tangible Book Value Per Share
13.8017.652.2116.1924.25